BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 28412458)

  • 1. Clinical significance of the B7-H4 as a novel prognostic marker in breast cancer.
    Huang H; Li C; Ren G
    Gene; 2017 Aug; 623():24-28. PubMed ID: 28412458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical significance of the B7-H4 coregulatory molecule as a novel prognostic marker in gastric cancer.
    Arigami T; Uenosono Y; Ishigami S; Hagihara T; Haraguchi N; Natsugoe S
    World J Surg; 2011 Sep; 35(9):2051-7. PubMed ID: 21748517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of B7-H4 expression in matched primary pancreatic cancer and liver metastases.
    Qian Y; Sang Y; Wang FX; Hong B; Wang Q; Zhou X; Weng T; Wu Z; Zheng M; Zhang H; Yao H
    Oncotarget; 2016 Nov; 7(44):72242-72249. PubMed ID: 27750217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. B7-H3 and B7-H4 expression in phyllodes tumors of the breast detected by RNA in situ hybridization and immunohistochemistry: Association with clinicopathological features and T-cell infiltration.
    Kim GE; Kim NI; Park MH; Lee JS
    Tumour Biol; 2018 Nov; 40(11):1010428318815032. PubMed ID: 30486739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. B7-H4 is a prognostic biomarker for poor survival in patients with pancreatic cancer.
    Shen L; Qian Y; Wu W; Weng T; Wang FXC; Hong B; Wu Z; Wang Q; Sang Y; Zhang H; Zhou X; Yao H
    Hum Pathol; 2017 Aug; 66():79-85. PubMed ID: 28600225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Upregulation of B7-H4 promotes tumor progression of intrahepatic cholangiocarcinoma.
    Xie N; Cai JB; Zhang L; Zhang PF; Shen YH; Yang X; Lu JC; Gao DM; Kang Q; Liu LX; Zhang C; Huang XY; Zou H; Zhang XY; Song ZJ; Sun HX; Fu BM; Ke AW; Shi GM
    Cell Death Dis; 2017 Dec; 8(12):3205. PubMed ID: 29235470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of combined expression of B7-H3 and B7-H4 as prognostic marker in esophageal cancer patients.
    Chen L; Xie Q; Wang Z; Shi L; Wu C; Jiang J
    Oncotarget; 2016 Nov; 7(47):77237-77243. PubMed ID: 27764786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. B7-H4 induces epithelial-mesenchymal transition and promotes colorectal cancer stemness.
    Feng Y; Yang Z; Zhang C; Che N; Liu X; Xuan Y
    Pathol Res Pract; 2021 Feb; 218():153323. PubMed ID: 33429327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. B7-H1 and B7-H4 expression in colorectal carcinoma: correlation with tumor FOXP3(+) regulatory T-cell infiltration.
    Zhao LW; Li C; Zhang RL; Xue HG; Zhang FX; Zhang F; Gai XD
    Acta Histochem; 2014 Sep; 116(7):1163-8. PubMed ID: 25053455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic role of B7-H4 in patients with non-small cell lung cancer: A meta-analysis.
    Tan Z; Shen W
    Oncotarget; 2017 Apr; 8(16):27137-27144. PubMed ID: 28404927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Expression and significance of immune checkpoint B7-homolog 4 in endometrial cancer].
    Zong LJ; Xiang Y; Yu SN; Lu ZH; Chen J; Huang WH
    Zhonghua Fu Chan Ke Za Zhi; 2022 Dec; 57(12):921-931. PubMed ID: 36562226
    [No Abstract]   [Full Text] [Related]  

  • 12. B7-H3, B7-H4, Foxp3 and IL-2 expression in cervical cancer: Associations with patient outcome and clinical significance.
    Huang C; Zhou L; Chang X; Pang X; Zhang H; Zhang S
    Oncol Rep; 2016 Apr; 35(4):2183-90. PubMed ID: 26848032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aberrant expression of B7-H4 correlates with poor prognosis and suppresses tumor-infiltration of CD8+ T lymphocytes in human cholangiocarcinoma.
    Zhao X; Guo F; Li Z; Jiang P; Deng X; Tian F; Li X; Wang S
    Oncol Rep; 2016 Jul; 36(1):419-27. PubMed ID: 27177355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. B7-H4 is a potential prognostic biomarker of prostate cancer.
    Li H; Piao L; Liu S; Cui Y; Xuan Y
    Exp Mol Pathol; 2020 Jun; 114():104406. PubMed ID: 32088189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. B7-H3 and B7-H4 Expression in Breast Cancer and Their Association with Clinicopathological Variables and T Cell Infiltration.
    Kim NI; Park MH; Kweon SS; Lee JS
    Pathobiology; 2020; 87(3):179-192. PubMed ID: 32088722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. B7-H4 expression is associated with cancer progression and predicts patient survival in human thyroid cancer.
    Zhu J; Chu BF; Yang YP; Zhang SL; Zhuang M; Lu WJ; Liu YB
    Asian Pac J Cancer Prev; 2013; 14(5):3011-5. PubMed ID: 23803071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of B7-H4 and hepatitis B virus X in hepatitis B virus-related hepatocellular carcinoma.
    Hong B; Qian Y; Zhang H; Sang YW; Cheng LF; Wang Q; Gao S; Zheng M; Yao HP
    World J Gastroenterol; 2016 May; 22(18):4538-46. PubMed ID: 27182163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. B7-H4 expression is correlated with tumor progression and clinical outcome in urothelial cell carcinoma.
    Fan M; Zhuang Q; Chen Y; Ding T; Yao H; Chen L; He X; Xu X
    Int J Clin Exp Pathol; 2014; 7(10):6768-75. PubMed ID: 25400757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. B7-H4 expression is associated with tumor progression and prognosis in patients with osteosarcoma.
    Dong Q; Ma X
    Biomed Res Int; 2015; 2015():156432. PubMed ID: 25954746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Expressions of osteopontin and B7-H4 in epithelial ovarian neoplasm and their significance].
    Zhang LL; Shao SL; Wu Y
    Chin J Cancer; 2010 Jan; 29(1):25-9. PubMed ID: 20038306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.